FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
November 30, 2021 at 10:59 AM EST
The advisory committee will decide whether the benefits of Merck’s experimental antiviral COVID-19 pill outweigh its risks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|